Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 1st October 2014
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

"Questionable results" yielded by feline diabetes research
cat
Dr Niessen says human-style clinical trials are needed to compare the effectiveness of different treatments.
RVC's systematic review finds more collaboration and larger sample sizes are needed

Past research on feline diabetes lacks collaboration and is based on low-level evidence, leading to "questionable results". This is according to a systematic review of research papers carried out by the Royal Veterinary College (RVC).

"Current research into the condition is sporadic, lacking a long-term vision and not collaborative," says Dr Stijn Niessan, who launched the RVC's Feline Diabetic Remission Clinic (FDRC) with his team in 2013.

Dr Niessan believes human-style clinical trials are the best method to compare remission rates with different types of insulin.

"The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.

“This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits."

Researchers say treatment recommendations are based on past research with sample sizes of as few as eight cat and the largest samples contained 50 to 60 cats. Statistical tests carried out by the FDRC team suggest that a minimum of 80 to 90 cats are required to accurately compare different treatments.

Dr Niessan says more collaboration is needed both nationally and internationally to address the inconsistencies in the treatment of feline diabetes.

"A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition," he explains. "The owner could then go online and find a third way. These treatments aren’t necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way.

"This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.